Ron Bentsur - 05 Nov 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
05 Nov 2025
Net transactions value
+$28,600
Form type
4
Filing time
06 Nov 2025, 08:01:11 UTC
Previous filing
03 Jan 2025
Next filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BENTSUR RON Chairman & CEO, Director, 10%+ Owner C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275, FORT LEE /s/ Ron Bentsur 06 Nov 2025 0001251213

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $28,600 +5,000 +0.14% $5.72 3,525,924 05 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 676,759 shares of restricted stock.